Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
Sign Up to like & getrecommendations! Published in 2019 at "Antibodies"
DOI: 10.3390/antib8010021
Abstract: The development of hybridoma technology for producing monoclonal antibodies (mAbs) by Kohler and Milstein (1975) counts as one of the major medical breakthroughs, opening up endless possibilities for research, diagnosis and for treatment of a… read more here.
Keywords: innovative biosimilar; immunogenicity; antibodies immunogenicity; monoclonal antibodies ... See more keywords